Congressman Jesús “Chuy” García Joins Colleagues to Introduce Legislation to Lower Prescription Drug Prices

February 7, 2019
Press Release

Washington, D.C.- Congressman Jesús “Chuy” García (IL-04) joined colleagues from the House and Senate today to unveil legislation to put patients over profits by addressing the prescription drug affordability crisis. The Medicare Negotiation and Competitive Licensing Act, would enable the federal government to negotiate prices of prescription drugs.

“Latinos are in the highest risk bracket for those likely to have type-2 diabetes, placing a large percentage of the population I represent in my district at risk. The cost of insulin has nearly doubled from 2012 to 2016, putting patients’ health at risk. My constituents have been asking me to support legislation to make medication, such as insulin, more affordable. This can be done, and it makes the difference between life and death for many hard-working people across our country.

“My wife is an ambassador for people with disabilities because she has Multiple Sclerosis. The cost of providing the medicine she needs to walk, to live, to be a grandmother is exorbitant. This is an emergency for so many Americans, and pharma needs to do the right thing for people,” said Congressman García.

"In the past year alone, the United States spent more than $333 billion for prescription drugs. Over 40% was paid by the Federal Government through Medicare, Medicaid, and the VA. This legislation is a bold approach that relies on market-driven competition to restrain monopoly pricing and reign in the exponential costs of life-saving medications. According to a 2018 survey by the Kaiser Family Foundation, 24 percent of respondents reported that they or a family member had not filled a prescription, cut pills in half or skipped doses due to cost."